Reneo Pharmaceuticals launches REN001 clinical trial in McArdle disease
Reneo Pharmaceuticals has initiated a phase 1b clinical trial of REN001 in glycogen storage disease type V (GSD V), also called McArdle disease. The California-based ... Read More
Talaris initiates FREEDOM-1 clinical trial for FCR001 in LDKT recipients
Talaris Therapeutics has initiated the phase 3 FREEDOM-1 clinical trial to evaluate its investigational, allogeneic cell therapy FCR001 in living donor kidney transplant (LDKT) recipients. ... Read More
Shocking facts of heartburn drugs causing kidney damage revealed
A new study published in the journal Kidney International has revealed that prolonged and excessive intake of heartburn drugs may lead to serious kidney disorders ... Read More